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We identified risk factors for Buruli ulcer (BU) in Benin
in an unmatched case-control study at the Centre Sanitaire
et Nutritionnel Gbemoten in southern Benin. Atotal of 2,399
persons admitted from 1997 through 2003 and 1,444
unmatched patients with other conditions in 2002 were
recruited. Adjusted odds ratios were determined for age,
sex, place of residence, Mycobacterium bovis BCG vacci-
nation at birth, type of water for domestic use, and occupa-
tion. Children <15 years of age and adults >49 years of age
had a higher risk for BU. Use of unprotected water from
swamps was associated with increased risk for BU; this
association was strongest in adults >49 years of age. Sex
was not a risk factor for BU. Our data showed that BU was
mainly associated with age, place of residence, and water
sources in all age groups. Risk for BU was higher in BCG-
vaccinated patients >5 years of age.
T
he World Health Organization (WHO) defines Buruli
ulcer (BU) as “an infectious disease involving the
skin, caused by Mycobacterium ulcerans, characterized by
a painless nodule, papule, plaque or edema, evolving into
a painless ulcer with undermined edges, often leading to
invalidating sequelae. Sometimes bones are destroyed.”
(1). After tuberculosis and leprosy, BU is the third most
common mycobacterial disease (1). Incidences have
increased recently, especially in West Africa (2–6). In
1997, WHO recognized BU as an emerging public health
problem.
Classically, BU is a disease of rural areas and associat-
ed with wetlands. Endemic foci exist in tropical Africa, the
Americas, Australia, and Asia (1,7,8). Epidemiologic
observations concentrate on descriptive information or
identification of new foci; however, few case-control stud-
ies have been published (2,3,9). Our objective was to
assess sociodemographic variables and selected environ-
mental factors associated with BU in Benin.
Patients and Methods
Setting
Benin is a West African country with 6,752,569 inhab-
itants: 51% are female (Third General Census, 2002.
unpub. data). The population is young: 48% are <15 years
old. Benin was formerly divided into 6 regions
(Atlantique, Mono, Borgou, Zou, Oueme, and Atacora);
however, each region is now divided into 2 regions
(Atlantique/Littoral, Mono/Couffo, Borgou/Alibori,
Zou/Colline, Oueme/Plateau, and Atacora/Donga).
The Centre Sanitaire et Nutritionnel Gbemoten
(CSNG) in Zou, Benin, is the regional referral center for
BU treatment. From 1989 through 2003, CSNG treated
>4,000 BU patients. This study included the period
1997–2003. The population of Zou in 2001 was 1,112,943.
Sample Size
Endemic foci of BU are associated with stagnant bod-
ies of water (ponds, backwaters, and swamps). Data from
the Benin Demographic and Health Survey (DHS) 2001
show that 34.5% of the Zou community drink unprotected
water (rain water, unprotected well, surface water) (10).
The sample size calculated with EpiInfo (Centers for
Disease Control and Prevention, Atlanta, GA, USA) was
147 cases and 147 hospital controls (control-case ratio 1,
odds ratio [OR] > 2, proportion of exposition to unpro-
tected water in controls 34.5%, power 80% [1 – β], and
95% confidence level α = 0.05).
Since we had a large amount of data at our disposal, we
analyzed the entire group of case-patients and all controls
recruited during 6 months in 2002. The duration of enroll-
ment of controls was limited to 6 months because of prob-
lems of availability of the healthcare staff.
Case-Patient Recruitment
All patients with suspected BU were examined by a
physician (C.Z.) and the nurse (J.A.) in charge of the
CNSG. Historic and clinical data were recorded on stan-
dard forms. One or more of the following features
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nodular, indurated plaque or edematous lesion; >1 painless
chronic ulcers with undermined edges or a depressed scar;
swelling over a painful joint, suggesting bone involve-
ment; slowly developing lesion (weeks or months); no
fever or regional lymphadenopathy; and residence or trav-
el in a zone endemic for BU.
CSNG admitted 2,468 suspected BU patients from
1997 through 2003. Sixty-nine patients were excluded: 56
with recurrent cases and 13 with another definitive diagno-
sis; 2,399 patients with BU were enrolled in the study.
Hospital Control Recruitment
In 2002, controls were recruited among patients seen at
CSNG for conditions other than BU: 21% had malaria,
6.0% had bronchitis, 5.6% had rheumatism, and 5.5% had
parasitosis. The frequency of all other conditions was
<5%.
CSNG had 2 types of clinics: 1 for persons <5 years old
and 1 for all others. Both clinics interviewed and examined
people 3 times a week. For those >5 years old (group 1),
the head nurse interviewed all patients with a disease other
than BU. For those <5 years old (group 2), the parents or a
guardian of 5 subjects were interviewed from each clinic.
This method generated an unmatched control group of
1,444 persons.
Ethics
The Ethical Committee of Benin approved this study.
All persons or their mothers or guardians received infor-
mation about the disease and its treatment. All BU cases
and controls received treatment. Verbal consent was
obtained from participants or their parents or guardians.
Data Collection
Data were available from case files; information on the
same variables was collected from controls. Data were
then analyzed to identify potential risk factors for BU. All
data on age, sex, region of residence, occupational activi-
ty,  Mycobacterium bovis BCG scar status, and type of
domestic water used were recorded during the clinical
examination.
Water sources were categorized into 4 groups: pumped
water, river, mixed sources (pumped and river), and
swamps. The 4 groups were classified into 2 groups: pro-
tected water (pumped) and unprotected water (all other
sources). Residences were categorized as Zou, Oueme, and
other.
A total of 525 children were in group 1: 339 BU cases
and 186 controls. Complete data, except water sources,
were available for 339 persons (case-patients and con-
trols). These persons were analyzed by logistic regression.
When water source was entered into the model, this num-
ber decreased to 246. Age was divided into 3 groups: <1
year, 1–2 years, and 3–4 years. Occupation was not intro-
duced into the model for children <5 years of age.
Group 2 had 3,252 persons: 2,032 BU patients and
1,220 controls. Because data were missing for 930 persons
(775 BU patients and 155 controls), 2,322 persons were
analyzed by logistic regression. This number was reduced
to 1,775 and 1,332 persons, respectively, when water
sources and water sources or activities were introduced
into the model. Age was divided into 4 groups based on the
ORs shown in Table 1: 5–14 years, 15–29 years, 30–49
years, and >50 years. Occupation was grouped as follows:
attending or not attending school (for school-age persons),
farmer, housewife, and other (e.g., salesperson, tailor, hair-
dresser, or teacher).
Data Analysis
Data were analyzed with SPSS version 9.05 (SPSS Inc.,
Chicago, IL, USA) and EpiInfo version 6.02. Because of
the selection method of controls in the clinic for children,
control children <5 years old were underrepresented, and
analysis was performed separately for these children.
Crude ORs and 95% confidence intervals (CIs) were cal-
culated to evaluate the association between BU and vari-
ous factors. Contingency tables were analyzed with the
Pearson χ2 test.
Abackward elimination procedure, based on likelihood
ratio, was used to select variables to include in logistic
regression models. Because age and occupation were cor-
related (Spearman ρ = 0.626), we introduced either age or
occupation into the logistic models. Some interactions
were tested in the logistic model including age with the
likelihood ratio test. Interaction between age and water
source appeared significant; thus, separate logistic models
were established for each age category. Because sex and
occupation were virtually redundant (e.g., female and
housewife), models including occupation were established
separately for each sex. Adjusted ORs and 95% CIs were
derived from the final logistic models. For these models,
goodness of fit was assessed with the Hosmer and
Lemeshow test.
Results
Group 1
Table 2 shows results of univariate analysis for group 1
(crude ORs and 95% CIs). Age, place of residence, and
water sources were associated with BU. Sex was not asso-
ciated with BU. The risk for BU was ≈3× higher in chil-
dren without a BCG scar. BU was associated with having
a BCG scar (p = 0.047). Risk for BU was particularly high
when the water source was a swamp compared with
pumped water (OR 47.59, 95% CI 13.76–164.61).
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1. In this model, age, place of residence, and water sources
were associated with BU. The risk for BU was high in chil-
dren 3–4 years old (OR 6.74, 95% CI 2.67–17.03), those
living in Oueme (OR 2.78, 95% CI 1.35–5.70) or other
places (OR 9.74, 95% CI 2.27–41.76), and those using
unprotected water (OR 2.27, 95% CI 1.22–4.22). Sex and
a BCG scar were not associated with BU.
Group 2
Table 1 shows distribution of case-patients and controls
by age group. The age groups used (5–14, 15–29, 30–49,
and >50 years) were based on the crude ORs found. The
30- to 49-year age group had the lowest risk for BU.
Table 4 shows results of univariate analyses for persons
>5 years old. All variables were associated with BU infec-
tion. Risk for BU was highest in persons using mixed
sources of water (OR 16.72, 95% CI 10.63–26.31). The
risk for BU in those using river water was similar to that of
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sified as protected and unprotected water, the OR was 5.15
(95% CI 4.22–6.28) for those using unprotected water.
In the 5–14-year age group, no difference concerning
schooling was observed between case-patients and con-
trols. In those >14 years old, more controls were house-
wives than were case-patients (28.5% vs. 2.6%), and more
case-patients were farmers than were controls (49.4% vs.
29.0%).
Univariate analyses by sex and occupation showed that
in males, being school age and being a farmer produced
the higher risk for BU (data not shown). Young boys
(independent of school attendance) had the greatest risk.
In females, school-age girls and farmers had similar risks
for BU, but housewives had the lowest risk (data not
shown).
Table 5 shows results of logistic regression analyses of
risk factors for BU in persons >5 years old. Occupation
was excluded because it correlated with age. The model
included age, BCG scar, place of residence, and water
sources but excluded sex (not significant). When adjusted
for other variables, children 5–14 years old had a higher
risk for BU (OR 11.64, 95% CI 8.01–16.91). The OR (95%
CI 3.04–6.27) for BU was 4.36 in those >50 years old.
Risk for BU was associated with exposure to unprotected
water sources (OR 4.62, 95% CI 3.61–5.90). Absence of a
BCG scar decreased the risk for BU (OR 0.40, 95% CI
0.31–0.52). Living a greater distance from CSNG was
strongly associated with an increased risk for BU (OR
13.02, 95% CI 8.03–21.11).
Logistic regression showed a strong interaction
between age and water source. Thus, a logistic model was
produced for each age group. Adjusted ORs and 95% CIs
derived from models in the different age groups showed
that absence of a BCG scar decreased the risk for BU in all
age groups (data not shown). Risk for BU associated with
residence of patients was reduced in those >50 years old.
BU patients were 1.94× more likely than controls to use
unprotected water (OR 1.94, 95% CI 1.20–3.12), and ORs
were at least twice those in other age groups (data not
shown).
Final results of multivariate analyses by sex and occu-
pation in patients ≥5 years old showed that the risk for BU
was similar in both sexes for the following factors: BCG
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shown). Risk for BU in boys was strongly associated with
school age (OR 4.63, 95% CI 2.63–8.15). This risk was
lower in girls (OR 2.75, 95% CI 1.59–4.76). Risk in
female farmers was strongly increased (OR 3.51, 95% CI
1.97–6.26). Housewives showed a strong decreased risk
for BU (OR 0.06, 95% CI 0.03–0.13).
Discussion
This is the first large case-control study to describe
sociodemographic and environmental factors associated
with BU. Our data show that BU was associated with age,
place of residence, and water sources for all persons, and
that BU was associated with a BCG scar in persons >5
years old.
In accordance with previous studies (1–3,11), the risk
for BU was higher in children <15 years old. Children 3–4
years old had an increased risk for BU if they used unpro-
tected water and lived in areas endemic for BU. That cloth-
ing provides protection against BU has already been
reported in Côte d’Ivoire (3). In Africa, infants <1 year of
age are often protected by clothes, bonnets, and booties. At
≈1–2 years of age, children begin to walk and play in dirt
near their home, and those 3–4 years of age are more inde-
pendent and roam freely in the environment, usually scant-
ily clothed, which increases exposure to a contaminated
environment. Use of unprotected water increases BU risk
(OR >40), especially in children <5 years old. These asso-
ciations have been previously reported (9,12,13).
Molecular studies showed M. ulcerans in water, mud, fish,
aquatic insects, and snails from swamps in regions endem-
ic for BU (14–18). Material from swamps, ponds, or river
regions may contaminate skin surfaces with M. ulcerans,
which can result in introduction of the causative agent into
skin when it is broken by trauma or insect bites (15,19).
Children 5–14 years old and persons >49 years old
were at higher risk for BU. Their attire and contact with
environmental sources of M. ulcerans may be a relevant
factor. Elderly persons through repeated episodes of expo-
sure to M. ulcerans may acquire latent infections that are
reactivated by age-related immunosuppression. Results
from the logistic model in the ≥50-year age group support
this concept. In this age group, risk for BU showed a lower
correlation with unprotected water than in other age
groups.
Although adults 15–49 years old are frequently
exposed to wetlands, their risk for BU was lower, which
suggests acquired resistance to the disease. We speculate
that this resistance may be related to acquired specific im-
munity or to cross-immunity from other mycobacterioses
(20).
We previously reported that men >59 years old in Zou
had a higher risk for BU than women, but men and women
in the <59-year-old group were equally at risk (11). Our
present study did not confirm sex differences in either
those >50 or <50 years of age. These 2 studies differ in
design: the earlier study (11) of the general population of
Zou showed that 43% were boys and men. In this study,
the percentage of male control subjects was slightly high-
er (47%) and may suggest that no differences in risk exist.
The percentages of school-age and nonschool-age male
BU patients increased relative to controls, while the per-
centages of female farmers and school-age and nonschool-
age girls were nearly equal. Although we did not evaluate
specific work or duties, girls often carry water and perform
other tasks, but young boys usually play and frequent con-
taminated environments. Reduced risk for BU in house-
wives may be related to their reduced contact with
contaminated environments. Differences between age and
occupation may reflect differences in age-specific frequen-
cy and intensity of exposure to M. ulcerans.
From 1997 to 2001, CSNG received patients mainly
from the Zou Region (6). Few patients come to CSNG
from remote areas for treatment of diseases other than BU.
The total number of BU patients is likely underestimated
because of complex socioeconomic factors involved in
care seeking and treatment of chronic diseases such as BU
(21).
Studies that evaluated the presence or absence of BCG
scars to determine vaccination status reported that scars
develop in most vaccinated persons (22,23). No associa-
tion was found between BU and BCG status in children <5
years old after adjustment for age. In persons >5 years old,
a BCG scar resulted in a risk factor of 2.5 for BU com-
pared with those without a BCG scar (Table 5). Our results
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BCG vaccination partially protects against BU (24,25).
However, this protection seemingly decreased after 6
months (24).
In children in Benin >5 years old, a BCG scar may rep-
resent a risk factor for BU. Vaccination may rarely intro-
duce M. ulcerans intradermally from contaminated skin
(26). At CSNG, BU developed in several patients at the site
of BCG vaccination (J. Aguiar, C. Steunou, C. Zinsou,
unpub. data).
The efficacy of BCG in preventing dissemination of
tuberculosis in children is well known (27). BCG vaccina-
tion at birth also provides protection against the develop-
ment of M. ulcerans osteomyelitis (28,29). The disparity in
the results of our case-control study may reflect known
variations of efficacy of BCG (30). Factors related to host
and the causative agent may explain varying protection of
BCG against BU (31). An alternative explanation is varia-
tion of BCG coverage for controls (general population or
hospital controls) compared with BU patients (32). From
1993 to 1999, BCG vaccination coverage in Zou was sta-
ble (≈90%–100%). A matched case-control study in Benin
of neighborhood controls and BU cases to assess the effi-
cacy of BCG vaccination at birth is in progress. This ongo-
ing study will evaluate the validity of our findings (33).
Cases and controls are likely to have similar equal
exposures to environmental transmission factors for BU.
Results of our study are consistent when comparing data
from other regions in Benin or only from Zou.
This case-control study confirms findings of previous
studies, which indicated that children <15 years of age are
at highest risk for acquiring BU (1,6), and that in areas
endemic for BU, exposure to unprotected water is a risk
factor for the disease. (1,14). Our study demonstrates that
the association between BU and exposure to unprotected
water is not as strong in patients >50 years of age than in
other age groups. This suggests that BU in older people
may be related to reactivation of latent infections by M.
ulcerans. This study also demonstrates differences
between sexes, which may be associated with age-influ-
enced domestic, agricultural, and recreational activities.
BCG vaccination is a risk factor for BU in persons >5
years old. Because of the diversity of conditions encoun-
tered among controls, we do not believe that these condi-
tions have influenced our results.
Programs for provision of protected water for drinking
and domestic use would have the greatest effect on control
of BU in Benin. This effect could be accomplished by
drilling wells and supplying pumps. Appropriate educa-
tional programs that promote behavioral changes should
also reduce the frequency of BU.
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